These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 25925701

  • 21. Comparison of Iron Dosing Strategies in Patients Undergoing Long-Term Hemodialysis: A Randomized Controlled Trial.
    Bielesz B, Lorenz M, Monteforte R, Prikoszovich T, Gabriel M, Wolzt M, Gleiss A, Hörl WH, Sunder-Plassmann G.
    Clin J Am Soc Nephrol; 2021 Oct; 16(10):1512-1521. PubMed ID: 34470831
    [Abstract] [Full Text] [Related]

  • 22. The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
    Macdougall IC, Dahl NV, Bernard K, Li Z, Batycky A, Strauss WE.
    BMC Nephrol; 2017 Apr 03; 18(1):117. PubMed ID: 28372549
    [Abstract] [Full Text] [Related]

  • 23. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
    Wolf M, Rubin J, Achebe M, Econs MJ, Peacock M, Imel EA, Thomsen LL, Carpenter TO, Weber T, Brandenburg V, Zoller H.
    JAMA; 2020 Feb 04; 323(5):432-443. PubMed ID: 32016310
    [Abstract] [Full Text] [Related]

  • 24. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
    Lyseng-Williamson KA, Keating GM.
    Drugs; 2009 Feb 04; 69(6):739-56. PubMed ID: 19405553
    [Abstract] [Full Text] [Related]

  • 25. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial).
    Johansson PI, Rasmussen AS, Thomsen LL.
    Vox Sang; 2015 Oct 04; 109(3):257-66. PubMed ID: 25900643
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.
    Nephrol Dial Transplant; 1998 Oct 04; 13(10):2572-7. PubMed ID: 9794562
    [Abstract] [Full Text] [Related]

  • 34. The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale.
    Macdougall IC, Bock A, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Roubert B, Cushway T, Roger SD, FIND-CKD Study Investigators.
    Nephrol Dial Transplant; 2014 Apr 04; 29(4):843-50. PubMed ID: 24170814
    [Abstract] [Full Text] [Related]

  • 35. Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
.
    Macdougall IC, Strauss WE, Dahl NV, Bernard K, Li Z.
    Clin Nephrol; 2019 Apr 04; 91(4):237-245. PubMed ID: 30802204
    [Abstract] [Full Text] [Related]

  • 36. Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
    Abdel-Razeq H, Abbasi S, Saadi I, Jaber R, Abdelelah H.
    Drug Des Devel Ther; 2013 Apr 04; 7():939-44. PubMed ID: 24039403
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial.
    Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J.
    Am J Hematol; 2019 Sep 04; 94(9):1007-1014. PubMed ID: 31243803
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.